HIV Prevention for Injecting Drug Users in Kazakhstan
Couples Based HIV/STI Prevention for Injecting Drug Users in Kazakhstan
1 other identifier
interventional
600
1 country
1
Brief Summary
The proposed study addresses a significant public health threat of HIV, HCV and other STIs among a very high risk population of active IDUs and their sexual partners in Kazakhstan a region that is experiencing one of the fastest rising HIV epidemics in the world. There is a race to develop and implement effective HIV preventive interventions for IDUs and their sexual partners to stem the spread of HIV, HCV and other STIs in Almaty, Shu and other Central Asian towns along drug trafficking routes. The proposed study will test the effectiveness of a couplesbased HIV/STI risk reduction intervention to decrease new cases of HIV and Hepatitis C (HCV) and incidence of sexually transmitted infections (STIs), as well as to reduce unsafe injection practices and increase condom use among injecting drug users (IDUs) and their heterosexual, intimate partners in Kazakhstan.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2 hiv
Started May 2008
Longer than P75 for phase_2 hiv
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2008
CompletedFirst Submitted
Initial submission to the registry
September 19, 2012
CompletedFirst Posted
Study publicly available on registry
September 21, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2012
CompletedFebruary 27, 2014
February 1, 2014
4.5 years
September 19, 2012
February 25, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
The proportion of condom protected acts of vaginal and anal intercourse
12 months
The number of incidents of unclean syringes or needles in the past 90 days
12 months
Proportion of injection acts in which unclean needles or syringes were used in the past 90 days
12 months
The number of acts of unprotected vaginal and anal intercourse during the 90 days prior to the assessment period
12 months
Secondary Outcomes (1)
Number of people participants shared needles or syringes with in the past 90 days
12 months
Study Arms (2)
Couples Based HIV/STI Risk Reduction Intervention (CHSR)
EXPERIMENTALThe intervention includes a combination of empowerment and couple self-efficacy building strategies, which are employed to help couples overcome resistance to risk reduction.
Renaissance Wellness Promotion (WP)
ACTIVE COMPARATORThis intervention employs a psychoeducational approach to promote wellness, focusing on: maintaining a healthy diet on a low budget, exercising and fitness, stress reducing strategies and specific health related issues that affect IDUs, such as overdose.
Interventions
The intervention includes a combination of empowerment and couple self-efficacy building strategies, which are employed to help couples overcome resistance to risk reduction.
This intervention employs a psychoeducational approach to promote wellness, focusing on: maintaining a healthy diet on a low budget, exercising and fitness, stress reducing strategies and specific health related issues that affect IDUs, such as overdose.
Eligibility Criteria
You may qualify if:
- Couples are eligible to participate if both partners are aged 18 or older
- both partners identify each other as their main partner of the opposite sex and someone whom the participant considers a boy/girlfriend, spouse, lover and/ or parent of his/her child
- the relationship has existed at least 3 months
- each partner intends to remain together for at least 12 months
- at least one partner reports having had unprotected vaginal or anal intercourse with the other partner at least once in the previous 90 days
- at least one partner reports injecting drugs in the past 90 days
- neither partner has plans to relocate beyond a reasonable distance from the study site
You may not qualify if:
- Couples are excluded if either partner shows evidence of significant psychiatric, physical or neurological impairment that would limit effective participation as confirmed on a MiniMental State Examination and/or Quick Test
- either partner reports severe physical violence perpetrated by the other partner in the past year on the Revised Conflict Tactics Scale
- either partner is unable to commit to participate in the study through to completion
- either partner reports that the couple is planning a pregnancy within the next 18 months
- either partner is not fluent in Russian as determined during Informed Consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Global Health Research Center of Central Asia
Almaty, Kazakhstan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nabila El-Bassel
Columbia University
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of the Social Intervention Group, Global Health Research Center of Central Asia
Study Record Dates
First Submitted
September 19, 2012
First Posted
September 21, 2012
Study Start
May 1, 2008
Primary Completion
November 1, 2012
Study Completion
November 1, 2012
Last Updated
February 27, 2014
Record last verified: 2014-02